ACM
OLMA icon

ADAR1 Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

ADAR1 Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-81,399
Closed -$2.03M – 330
2025
Q4 		$2.03M Buy
81,399
+45,199
+125% +$804K 0.15% 99
2025
Q3 		$354K Buy
+36,200
New +$217K 0.03% 156
2024
Q3 		– Sell
-20,076
Closed -$217K – 325
2024
Q2 		$217K Buy
+20,076
New +$218K 0.04% 138

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

ADAR1 Capital Management's OLMA Position: Q1 2026 in Review

ADAR1 Capital Management sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 81,399 shares — an estimated $2.03M sold.

ADAR1 Capital Management first reported a position in OLMA in Q2 2024 and held it in 3 quarters. The position peaked at $2.03M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • ADAR1 Capital Management reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • ADAR1 Capital Management sold 81,399 Olema Pharmaceuticals shares in Q1 2026, an estimated $2.03M.
  • ADAR1 Capital Management first reported a position in Olema Pharmaceuticals in Q2 2024 and held it in 3 quarters.
  • ADAR1 Capital Management's Olema Pharmaceuticals position peaked at $2.03M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.